Hepatitis C virus (HCV) infection remains a major global health burden, affecting millions worldwide and contributing significantly to hepatocellular carcinoma (HCC) development.

Direct-acting antivirals (DAAs) have dramatically changed the landscape of chronic hepatitis C virus (HCV) treatment and ...

The Florida Department of Health report stated that three people were infected "very rare strain of the disease." ...

The move comes after a series of cuts to prevention and treatment efforts worldwide. Some functions might be moved to another ...

Based upon a successful engagement with the US Food and Drug Administration (FDA) at the End-of-Phase 2 meeting in January 2025, Atea is initiating a global Phase 3 program and expects patient ...

Researchers assessed epidemiologic trends of incident hepatitis C virus infection among patients with HIV infection engaged in care in the US.

HCV screening of pregnant and nonpregnant women in the US are increasing but remain suboptimal suggesting the need for ...

Officials and the media team in a group photograph Consultant Gastroenterologist, University of Ghana Medical Centre, Dr. Amoako Duah, has reiterated that viral hepatitis remains a major public health ...

The UK Health Security Agency (UKHSA) has recently launched a genomic surveillance programme to monitor the HCV and its ...

Hepatitis B can lead to liver disease. But we can prevent and manage this viral infection. Here’s what we know about the ...

Several studies have suggested that COVID-19 may increase a person’s risk of developing cancer or promote metastasis of existing cancer.

Scientists discovered a way to block hepatitis B infection using an anticancer drug, offering hope for new treatments.